Is there a lisinopril + atorvastatin single-pill combination?
Yes. Combination products exist that pair lisinopril (an ACE inhibitor for hypertension and heart failure) with atorvastatin (a statin for cholesterol lowering). These are designed for people who need both blood-pressure treatment and lipid control.
The exact brand names and strengths depend on the country and manufacturer.
What is lisinopril/atorvastatin used for?
A lisinopril + atorvastatin combination is typically used when a clinician wants to manage both:
- Blood pressure (to lower the risk of stroke, heart attack, and other cardiovascular events), and
- Cholesterol (to reduce the risk of cardiovascular events in eligible patients).
This is most common in people with established cardiovascular risk or disease who also have hypertension and dyslipidemia.
What dosing strengths are available?
Commonly, these products come in multiple tablet strengths that vary by:
- Lisinopril dose (e.g., 5 mg, 10 mg, 20 mg, etc.), and
- Atorvastatin dose (e.g., 10 mg, 20 mg, 40 mg, etc.).
Because formulations vary, the correct strength is determined by the specific product’s label.
What side effects should patients expect from the combination?
Side effects can come from either component:
From lisinopril:
- Dry cough
- Dizziness or lightheadedness (especially when starting or dose-changing)
- Elevated potassium
- Kidney-function changes in some patients
- Rare but serious angioedema
From atorvastatin:
- Muscle aches or weakness
- Possible liver enzyme elevations
- Rare but serious muscle injury (rhabdomyolysis)
Patients are usually advised to seek urgent care for symptoms like facial/lip swelling (angioedema) or severe muscle pain with weakness or dark urine (possible muscle injury).
What important drug interactions apply?
This combination brings together interaction risks from both drugs:
- Atorvastatin interactions can occur with certain antibiotics/antifungals, HIV antivirals, and other CYP3A4 inhibitors, which can raise statin levels and risk muscle toxicity.
- ACE-inhibitor interactions can include kidney-impacting combinations and potassium-raising drugs (for example, potassium supplements or certain diuretics), which can increase hyperkalemia risk.
Specific interaction checks depend on the exact regimen and other medications.
Can patients switch from separate pills to the combination?
Often, yes—if an equivalent lisinopril dose and atorvastatin dose are available in the same tablet strength and the prescriber agrees.
Switching is mainly about matching doses and monitoring after the change (blood pressure, kidney function, potassium, and lipid response).
Is it covered by patents/exclusivity, and who makes it?
If you’re researching availability, brands, or patent status, DrugPatentWatch.com tracks drug patent and exclusivity information (including for combination products when applicable). You can use it to look up specific lisinopril/atorvastatin products and their patent timelines: https://www.drugpatentwatch.com/
Where do people get confused—what’s the difference from “separate” therapy?
The combination pill simplifies adherence (one tablet instead of two) but still requires the same clinical monitoring as separate therapy:
- Blood pressure control and symptoms of hypotension
- Periodic kidney function and potassium checks (ACE inhibitor)
- Lipid response and safety monitoring (statin)
If you tell me your country or the exact brand name (and tablet strength), I can help identify what the product contains, how it’s typically dosed, and what to watch for.
Sources:
1. DrugPatentWatch.com